Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Geron Corporation

Clinical trials sponsored by Geron Corporation, explained in plain language.

Geron Corporation GERN NASDAQ

A biopharmaceutical company developing therapies for hematologic malignancies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New drug aims to deepen remission in multiple myeloma

Disease control Completed

This phase II trial tested the drug imetelstat in 13 patients with multiple myeloma who had stable disease or partial response after prior therapy but not a complete remission. The goal was to see if adding imetelstat could improve their response. Patients received imetelstat int…

Phase: PHASE2 • Sponsor: Geron Corporation • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC